Literature DB >> 23601319

Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes.

Alan Brown1, Christopher J Robinson, John T Gallagher, Tom L Blundell.   

Abstract

Fibroblast growth factors (FGFs) utilize cell surface heparan sulfate as a coreceptor in the assembly of signaling complexes with FGF-receptors on the plasma membrane. Here we undertake a complete thermodynamic characterization of the assembly of the FGF signaling complex using isothermal titration calorimetry. Heparin fragments of defined length are used as chemical analogs of the sulfated domains of heparan sulfate and examined for their ability to oligomerize FGF1. Binding is modeled using the McGhee-von Hippel formalism for the cooperative binding of ligands to a monodimensional lattice. Oligomerization of FGFs on heparin is shown to be mediated by positive cooperativity (α = 6). Heparin octasaccharide is the shortest length capable of dimerizing FGF1 and on longer heparin chains FGF1 binds with a minimal footprint of 4.2 saccharide units. The thermodynamics and stoichiometry of the ternary complex suggest that in solution FGF1 binds to heparin in a trans-dimeric manner before FGFR recruitment.
Copyright © 2013 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601319      PMCID: PMC3628569          DOI: 10.1016/j.bpj.2013.02.051

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

1.  Structural interactions of fibroblast growth factor receptor with its ligands.

Authors:  D J Stauber; A D DiGabriele; W A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Fibroblast growth factors, their receptors and signaling.

Authors:  C J Powers; S W McLeskey; A Wellstein
Journal:  Endocr Relat Cancer       Date:  2000-09       Impact factor: 5.678

3.  Energetics of heparin binding to human acidic fibroblast growth factor.

Authors:  Mercedes Guzmán-Casado; María M García-Mira; José M Sánchez-Ruiz; Guillermo Giménez-Gallego; Antonio Parody-Morreale
Journal:  Int J Biol Macromol       Date:  2002-12-20       Impact factor: 6.953

Review 4.  Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors.

Authors:  Holger Gohlke; Gerhard Klebe
Journal:  Angew Chem Int Ed Engl       Date:  2002-08-02       Impact factor: 15.336

5.  Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.

Authors:  Olga Ostrovsky; Bluma Berman; John Gallagher; Barbara Mulloy; David G Fernig; Maryse Delehedde; Dina Ron
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

6.  Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1.

Authors:  Andrew Beenken; Anna V Eliseenkova; Omar A Ibrahimi; Shaun K Olsen; Moosa Mohammadi
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

7.  Energetics of myo-inositol hexasulfate binding to human acidic fibroblast growth factor effect of ionic strength and temperature.

Authors:  M Guzmán-Casado; J M Sánchez-Ruiz; M El Harrous; G Giménez-Gallego; A Parody-Morreale
Journal:  Eur J Biochem       Date:  2000-06

8.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.

Authors:  L Pellegrini; D F Burke; F von Delft; B Mulloy; T L Blundell
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

9.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

Authors:  J Schlessinger; A N Plotnikov; O A Ibrahimi; A V Eliseenkova; B K Yeh; A Yayon; R J Linhardt; M Mohammadi
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

Review 10.  Heparin and heparan sulfate biosynthesis.

Authors:  Kazuyuki Sugahara; Hiroshi Kitagawa
Journal:  IUBMB Life       Date:  2002-10       Impact factor: 3.885

View more
  19 in total

1.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

2.  Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing.

Authors:  Eric Sterner; Sayaka Masuko; Guoyun Li; Lingyun Li; Dixy E Green; Nigel J Otto; Yongmei Xu; Paul L DeAngelis; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

3.  Heparan Sulfate Domains Required for Fibroblast Growth Factor 1 and 2 Signaling through Fibroblast Growth Factor Receptor 1c.

Authors:  Victor Schultz; Mathew Suflita; Xinyue Liu; Xing Zhang; Yanlei Yu; Lingyun Li; Dixy E Green; Yongmei Xu; Fuming Zhang; Paul L DeAngelis; Jian Liu; Robert J Linhardt
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

4.  Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Arwa Alghanmi; Ravi Kumar Gundampati; Srinivas Jayanthi; Ellen Fields; Monica Armstrong; Vanessa Weidling; Varun Shah; Shilpi Agrawal; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Arch Biochem Biophys       Date:  2018-07-19       Impact factor: 4.013

5.  Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.

Authors:  Yuejie Zhao; Arunima Singh; Yongmei Xu; Chengli Zong; Fuming Zhang; Geert-Jan Boons; Jian Liu; Robert J Linhardt; Robert J Woods; I Jonathan Amster
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-23       Impact factor: 3.109

Review 6.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

7.  Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.

Authors:  Jen-Chieh Lee; Sheng-Yao Su; Chun A Changou; Rong-Sen Yang; Keh-Sung Tsai; Michael T Collins; Eric S Orwoll; Chung-Yen Lin; Shu-Hwa Chen; Shyang-Rong Shih; Cheng-Han Lee; Yoshinao Oda; Steven D Billings; Chien-Feng Li; G Petur Nielsen; Eiichi Konishi; Fredrik Petersson; Thomas O Carpenter; Kesavan Sittampalam; Hsuan-Ying Huang; Andrew L Folpe
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

8.  The conundrum of the high-affinity NGF binding site formation unveiled?

Authors:  Sonia Covaceuszach; Petr V Konarev; Alberto Cassetta; Francesca Paoletti; Dmitri I Svergun; Doriano Lamba; Antonino Cattaneo
Journal:  Biophys J       Date:  2015-02-03       Impact factor: 4.033

9.  Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma.

Authors:  Naiqing Liu; Jingyu Zhang; Shuxiang Sun; Liguang Yang; Zhongjin Zhou; Qinli Sun; Jun Niu
Journal:  Onco Targets Ther       Date:  2015-03-09       Impact factor: 4.147

10.  Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.

Authors:  John Gallagher
Journal:  Int J Exp Pathol       Date:  2015-07-15       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.